ranibizumab
This template is part of the ArticlePlaceholder extension. If you want to adjust it, please consider making your changes upstream.
kemia kombinaĵo
estas
speco de kemiaĵo
subaro de
kemia formulo
C₂₁₅₈H₃₂₈₂N₅₆₂O₆₈₁S₁₂
aktiva ingredienco en
Lucentis[10]
kuracata malsano
diabeta retinopatio[12]
retinopatio[12]
Kuhnt-Junius degeneration[12]
cystoid macular edema[12]
retinal vein occlusion[12]
exudative vitreoretinopathy 1[12]
macular retinal edema[12]
okula malsano[12]
metodo de liverado
intravitreal administration
legal status (medicine)
boxed warning[13]
medikamenta kategorio pri gravedo
Usona medikamenta prigraveda kategorio C
havas econ
havas parton
Referenco
- ↑ 1,0 1,1 NDF-RT, 19 jan. 2016, angla lingvo, RANIBIZUMAB, N0000171789
- ↑ 2,0 2,1 2,2 DrugBank, angla lingvo, 17 nov. 2015, 01270, Ranibizumab
- ↑ 3,0 3,1 3,2 ChEMBL, 19 jan. 2016, angla lingvo, Ranibizumab, CHEMBL1201825
- ↑ OpenAlex, 26 jan. 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
- ↑ UMLS 2023, 25 maj. 2023, inferred by common MeSH mappings on source and on Wikidata
- ↑ https://mednet-communities.net/inn/db/ViewINN.aspx?i=8313
- ↑ N0000171789, 26 feb. 2018, NDF-RT
- ↑ Freebase Data Dumps, 28 okt. 2013
- ↑ 9,0 9,1 DrugBank, angla lingvo, 17 nov. 2015, Ranibizumab, 01270
- ↑ http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000715/human_med_000890.jsp, 22 mar. 2017, EMEA/H/C/000715
- ↑ Recommended INN: List 52, 2004
- ↑ 12,0 12,1 12,2 12,3 12,4 12,5 12,6 12,7 12,8 Drug Indications Extracted from FAERS, 2 okt. 2018
- ↑ FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links., https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802
- ↑ Medical Subject Headings, 15 mar. 2018, D000069579